1.29
price down icon7.86%   -0.11
after-market After Hours: 1.34 0.05 +3.88%
loading

Mira Pharmaceuticals Inc Stock (MIRA) Forecast

The Mira Pharmaceuticals Inc (MIRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.478, representing a +247.13% increase from the current price of $1.29. The highest analyst price target is $4.80, and the lowest is $4.1561.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MIRA Price Target
Average 5.9217 (+359.05% Upside)
loading

Is Mira Pharmaceuticals Inc (MIRA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 51.38 Neutral
STOCH(9,6) 69.46 Neutral
STOCHRSI(14) 89.29 Sell
MACD(12,26) 0.0587 Sell
ADX(14) 24.02 Neutral
William %R -50.00 Neutral
CCI(14) 12.66 Neutral
Buy: 0 Sell: 2 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.352
Sell
1.3432
Sell
MA20
1.3205
Sell
1.3034
Sell
MA50
1.1272
Buy
1.2103
Buy
MA100
1.1257
Buy
1.1814
Buy
MA200
1.2394
Buy
1.1713
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, MIRA could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on MIRA, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 51.38 indicates that MIRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 69.46 indicates that MIRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 89.29 indicates that MIRA is oversold. This suggests that MIRA price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 24.02 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 12.66 indicates that MIRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term MIRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Mira Pharmaceuticals Inc financial reports and earnings history, Mira Pharmaceuticals Inc (MIRA) stock could reach $25.86 by 2030, $68.74 by 2040 and $104.50 by 2050. See the projected annual prices until 2050 of the Mira Pharmaceuticals Inc stock below:

  • Mira Pharmaceuticals Inc (MIRA) is expected to reach an average price of $73.11 in 2035, with a high prediction of $72.81 and a low estimate of $10.73. This indicates an $5,567% rise from the last recorded price of $1.29.
  • Mira Pharmaceuticals Inc (MIRA) stock is projected to chart a bullish course in 2040, with an average price target of $61.91, representing an $4,700% surge from its current level. The forecast ranges from a conservative $61.92 to a sky-high $68.74.
  • Our analysts predict Mira Pharmaceuticals Inc (MIRA) to jump 10,868% by 2045, soaring from $21.44 to an average price of $141.49, potentially reaching $141.46. While $21.44 is the low estimate, the potential upside is significant.
  • Mira Pharmaceuticals Inc (MIRA) stock is expected to climb by 2050, reaching an average of $92.97, a $7,107% jump from its current level. However, a wide range of estimates exists, with high and low targets of $104.50 and $93.27, respectively, highlighting the market's uncertainty.

Mira Pharmaceuticals Inc Stock (MIRA) Year by Year Forecast

Mira Pharmaceuticals Inc Stock (MIRA) Price Forecast for 2025

Mira Pharmaceuticals Inc Stock (MIRA) is expected to reach an average price of $5.1785 in 2025, with a high prediction of $10.33 and a low estimate of $0.0235. This indicates an +301.43% rise from the last recorded price of $1.29.
Month Average Low High Change from today's price
July, 2025 $4.1457 $4.1561 $4.80 +221.37%
August, 2025 $3.1564 $3.2114 $3.4229 +144.68%
September, 2025 $2.0171 $2.1271 $2.8928 +56.36%
October, 2025 $1.2444 $1.2584 $1.7487 -3.53%
November, 2025 $12.33 $0.8471 $9.4421 +855.76%
December, 2025 $10.66 $9.9606 $10.33 +726.74%

Mira Pharmaceuticals Inc Stock (MIRA) Price Forecast for 2026

The predicted value for Mira Pharmaceuticals Inc (MIRA) in 2026 is set at an average of $8.4596. Estimates vary from a peak of $15.25 to a trough of $1.6706, indicating an +555.78% surge from the present price of $1.29.
Month Average Low High Change from today's price
January, 2026 $10.90 $11.08 $11.00 +745.23%
February, 2026 $7.2421 $7.6421 $8.2708 +461.40%
March, 2026 $8.6207 $8.749 $8.6635 +568.27%
April, 2026 $7.0164 $7.0684 $8.1078 +443.90%
May, 2026 $5.5849 $5.7349 $6.6335 +332.94%
June, 2026 $4.0335 $4.1735 $5.1421 +212.67%
July, 2026 $2.6676 $2.7392 $3.4306 +106.79%
August, 2026 $15.02 $1.6706 $14.72 +1,065%
September, 2026 $15.97 $14.78 $14.54 +1,138%
October, 2026 $15.50 $15.53 $15.25 +1,101%
November, 2026 $11.63 $11.85 $14.70 +801.54%
December, 2026 $11.84 $11.32 $12.05 +818.16%

Mira Pharmaceuticals Inc Stock (MIRA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Mira Pharmaceuticals Inc (MIRA) is $11.25, with a high forecast of $20.00 and a low forecast of $2.4942. This indicates an +772.00% increase from the last price of $1.29.
Month Average Low High Change from today's price
January, 2027 $9.9756 $10.28 $11.22 +673.30%
February, 2027 $8.1971 $8.2271 $9.3885 +535.43%
March, 2027 $5.7713 $5.9113 $7.6599 +347.39%
April, 2027 $4.2223 $4.2427 $5.0542 +227.31%
May, 2027 $3.1274 $2.4942 $3.7606 +142.43%
June, 2027 $19.36 $19.61 $20.00 +1,401%
July, 2027 $19.89 $19.89 $19.52 +1,442%
August, 2027 $16.28 $16.63 $19.50 +1,162%
September, 2027 $15.60 $15.00 $15.50 +1,109%
October, 2027 $13.57 $13.60 $14.89 +952.18%
November, 2027 $10.95 $11.19 $12.54 +748.66%
December, 2027 $7.6906 $8.35 $10.35 +496.17%

Mira Pharmaceuticals Inc Stock (MIRA) Price Forecast for 2028

In 2028, Mira Pharmaceuticals Inc (MIRA) is projected to reach an average price of $16.94, with a high projection of $30.56 and a low estimate of $3.3177. This indicates an +1,213% rise from the last price of $1.29.
Month Average Low High Change from today's price
January, 2028 $5.9549 $5.9749 $6.8492 +361.62%
February, 2028 $3.8393 $3.8742 $5.3434 +197.62%
March, 2028 $24.98 $3.3177 $25.28 +1,836%
April, 2028 $24.59 $24.43 $24.12 +1,807%
May, 2028 $20.19 $20.54 $23.75 +1,465%
June, 2028 $19.41 $18.68 $18.95 +1,405%
July, 2028 $16.99 $17.00 $18.68 +1,217%
August, 2028 $13.37 $13.61 $16.29 +936.53%
September, 2028 $10.76 $10.82 $12.66 +733.99%
October, 2028 $7.9556 $7.9856 $9.5427 +516.71%
November, 2028 $4.7771 $4.812 $7.2498 +270.32%
December, 2028 $30.95 $4.1413 $30.56 +2,300%

Mira Pharmaceuticals Inc Stock (MIRA) Price Forecast for 2029

The 2029 price forecast for Mira Pharmaceuticals Inc Stock (MIRA) is $20.41 on average, with a high prediction of $35.85 and a low estimate of $4.9648. This represents an +1,482% increase from the previous price of $1.29.
Month Average Low High Change from today's price
January, 2029 $29.07 $29.16 $29.35 +2,154%
February, 2029 $24.84 $26.76 $28.00 +1,826%
March, 2029 $23.38 $22.36 $22.11 +1,713%
April, 2029 $20.63 $20.71 $22.40 +1,500%
May, 2029 $16.83 $16.85 $19.77 +1,205%
June, 2029 $13.56 $13.61 $15.42 +951.15%
July, 2029 $10.13 $10.24 $12.72 +685.65%
August, 2029 $6.505 $6.519 $9.295 +404.26%
September, 2029 $38.16 $4.9648 $35.85 +2,858%
October, 2029 $33.64 $33.98 $34.29 +2,508%
November, 2029 $31.59 $31.77 $32.45 +2,349%
December, 2029 $25.65 $26.05 $28.39 +1,888%

Mira Pharmaceuticals Inc Stock (MIRA) Price Forecast for 2030

Mira Pharmaceuticals Inc Stock (MIRA) is expected to reach an average price of $23.46 in 2030, with a high forecast of $41.13 and a low forecast of $5.7884. This signifies an +1,718% surge from the last price of $1.29.
Month Average Low High Change from today's price
January, 2030 $23.74 $23.82 $25.86 +1,741%
February, 2030 $20.28 $20.33 $22.77 +1,472%
March, 2030 $16.56 $16.71 $19.32 +1,184%
April, 2030 $12.72 $12.86 $15.55 +886.25%
May, 2030 $8.4996 $8.5712 $11.55 +558.89%
June, 2030 $41.43 $5.7884 $41.13 +3,111%
July, 2030 $39.51 $38.90 $40.26 +2,963%
August, 2030 $36.76 $36.79 $37.90 +2,750%
September, 2030 $30.60 $30.82 $35.39 +2,272%
October, 2030 $27.96 $28.09 $29.31 +2,068%
November, 2030 $23.81 $24.11 $26.76 +1,746%
December, 2030 $19.74 $19.77 $22.65 +1,430%
drug_manufacturers_general SNY
$49.75
price down icon 1.43%
drug_manufacturers_general PFE
$23.97
price up icon 2.66%
$113.00
price up icon 0.48%
$289.98
price down icon 0.12%
drug_manufacturers_general MRK
$79.33
price up icon 0.46%
drug_manufacturers_general NVS
$118.02
price up icon 0.00%
Cap:     |  Volume (24h):